Monday, April 7, 1997
There is a spate of
pivotal clinical data due to be announced in the second quarter, but the word
on the Street is that investors shouldn't expect even good data to lift the
"This spring has
more key events than in the history of this industry," said UBS Securities
analyst Marc Ostro.